• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在治疗高血压的同时保护心脏代谢综合征中脆弱的胰岛。

Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

作者信息

Hayden Melvin R, Sowers James R

机构信息

Departments of Internal Medicine, Endocrinology Diabetes and Metabolism, and Diabetes and Cardiovascular Disease Research Center, School of Medicine, University of Missouri-Columbia, Health Sciences Center, Columbia, Missouri, USA.

出版信息

J Am Soc Hypertens. 2008 Jul-Aug;2(4):239-66. doi: 10.1016/j.jash.2007.12.002. Epub 2008 Jun 2.

DOI:10.1016/j.jash.2007.12.002
PMID:20409906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2867460/
Abstract

Hypertension, a multifactorial-polygenic disease, interacts with multiple environmental stressors and results in functional and structural changes in numerous end organs, including the cardiovascular system. This can result in coronary heart disease, stroke, peripheral vascular disease, congestive heart failure, end-stage renal disease, insulin resistance, and damage to the pancreatic islet. Hypertension is the most important modifiable risk factor for major health problems encountered in clinical practice. Whereas hypertension was once thought to be a medical condition based on discrete blood pressure readings, a new concept has emerged defining hypertension as part of a complex and progressive metabolic and cardiovascular disease, an important part of a cardiometabolic syndrome. The central role of insulin resistance, oxidative stress, endothelial dysfunction, metabolic signaling defects within tissues, and the role of enhanced tissue renin-angiotensin-aldosterone system activity as it relates to hypertension and type 2 diabetes mellitus are emphasized. Additionally, this review focuses on the effect of hypertension on functional and structural changes associated with the vulnerable pancreatic islet. Various classes of antihypertensive drugs are reviewed, especially their roles in delaying or preventing damage to the vulnerable pancreatic islet, and thus delaying the development of type 2 diabetes mellitus.

摘要

高血压是一种多因素多基因疾病,与多种环境应激源相互作用,导致包括心血管系统在内的众多终末器官发生功能和结构变化。这可引发冠心病、中风、外周血管疾病、充血性心力衰竭、终末期肾病、胰岛素抵抗以及胰岛损伤。高血压是临床实践中遇到的主要健康问题最重要的可改变风险因素。尽管高血压曾被认为是基于离散血压读数的一种病症,但一个新的概念已出现,将高血压定义为复杂且进行性代谢和心血管疾病的一部分,是心脏代谢综合征的重要组成部分。强调了胰岛素抵抗、氧化应激、内皮功能障碍、组织内代谢信号缺陷以及增强的组织肾素 - 血管紧张素 - 醛固酮系统活性在高血压和2型糖尿病中的作用。此外,本综述重点关注高血压对与易损胰岛相关的功能和结构变化的影响。对各类抗高血压药物进行了综述,尤其关注它们在延缓或预防易损胰岛损伤从而延缓2型糖尿病发生方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/46c221b69b74/nihms60608f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/c84d42fdf4e3/nihms60608f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/9a4dfe5cd6ed/nihms60608f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/f8ed4c477eee/nihms60608f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/59bb386bdd16/nihms60608f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/54c7a324318e/nihms60608f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/ff6e0514cd43/nihms60608f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/54757c484ca9/nihms60608f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/c9ea6ef59150/nihms60608f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/46c221b69b74/nihms60608f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/c84d42fdf4e3/nihms60608f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/9a4dfe5cd6ed/nihms60608f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/f8ed4c477eee/nihms60608f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/59bb386bdd16/nihms60608f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/54c7a324318e/nihms60608f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/ff6e0514cd43/nihms60608f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/54757c484ca9/nihms60608f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/c9ea6ef59150/nihms60608f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3329/2867460/46c221b69b74/nihms60608f9.jpg

相似文献

1
Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.在治疗高血压的同时保护心脏代谢综合征中脆弱的胰岛。
J Am Soc Hypertens. 2008 Jul-Aug;2(4):239-66. doi: 10.1016/j.jash.2007.12.002. Epub 2008 Jun 2.
2
Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.醛固酮:在心肾代谢综合征和耐药性高血压中的作用。
Prog Cardiovasc Dis. 2010 Mar-Apr;52(5):401-9. doi: 10.1016/j.pcad.2009.12.004.
3
Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell.高血压Ren2大鼠模型早期纤维化的胰岛超微结构研究。胰岛周细胞-星状细胞的新作用。
JOP. 2007 Nov 9;8(6):725-38.
4
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.糖尿病心血管并发症及事件的预防方法。
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
5
6
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.肾素-血管紧张素-醛固酮系统与心血管胰岛素抵抗中的氧化应激
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2009-23. doi: 10.1152/ajpheart.00522.2007. Epub 2007 Jun 22.
7
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.叙述性综述:醛固酮在代谢综合征和顽固性高血压中的作用所产生的新临床意义
Ann Intern Med. 2009 Jun 2;150(11):776-83. doi: 10.7326/0003-4819-150-11-200906020-00005.
8
9
First-line diuretics versus other classes of antihypertensive drugs for hypertension.一线利尿剂与其他类别降压药治疗高血压的比较。
Cochrane Database Syst Rev. 2023 Jul 13;7(7):CD008161. doi: 10.1002/14651858.CD008161.pub3.
10
Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.肾素-血管紧张素-醛固酮系统对心脏代谢综合征及心肾保护的干预作用
Ther Adv Cardiovasc Dis. 2007 Oct;1(1):27-35. doi: 10.1177/1753944707082697.

引用本文的文献

1
Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen.利维肝对接受基于伊立替康和奥沙利铂化疗方案的癌症患者脂肪肝改善的影响。
J Res Med Sci. 2018 Dec 28;23:111. doi: 10.4103/jrms.JRMS_793_17. eCollection 2018.
2
Barnidipine Real-Life Efficacy and Tolerability in Arterial Hypertension: Results from Younger and Older Patients in the BASIC-HT Study.巴尼地平在高血压治疗中的实际疗效和耐受性:BASIC-HT研究中年轻和老年患者的结果
Open Cardiovasc Med J. 2017 Nov 17;11:120-132. doi: 10.2174/1874192401711010120. eCollection 2017.
3

本文引用的文献

1
Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell.高血压Ren2大鼠模型早期纤维化的胰岛超微结构研究。胰岛周细胞-星状细胞的新作用。
JOP. 2007 Nov 9;8(6):725-38.
2
Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus.心脏代谢综合征和2型糖尿病中的胰岛淀粉样变与纤维化。
J Cardiometab Syndr. 2007 Winter;2(1):70-5. doi: 10.1111/j.1559-4564.2007.06159.x.
3
Introduction: organ involvement in the cardiometabolic syndrome.
Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.
导致意外体重增加或器官脂毒性改变的常见药物。
Curr Gastroenterol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11894-015-0479-4.
4
Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats.水飞蓟素(水飞蓟)对乙酰氨基酚诱导的自发性高血压大鼠肝毒性的保护作用。
Evid Based Complement Alternat Med. 2015;2015:538317. doi: 10.1155/2015/538317. Epub 2015 Mar 2.
5
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?与糖尿病相关的氨基酸特征是否与β受体阻滞剂引起的空腹血糖受损有关?
Circ Cardiovasc Genet. 2014 Apr;7(2):199-205. doi: 10.1161/CIRCGENETICS.113.000421. Epub 2014 Mar 13.
6
The past, present and future of renin-angiotensin aldosterone system inhibition.肾素-血管紧张素-醛固酮系统抑制的过去、现在和未来。
Int J Cardiol. 2013 Sep 1;167(5):1677-87. doi: 10.1016/j.ijcard.2012.10.007. Epub 2012 Oct 31.
7
Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.心肾代谢综合征和2型糖尿病中局部组织肾素-血管紧张素系统激活的可能机制
Cardiorenal Med. 2011;1(3):193-210. doi: 10.1159/000329926. Epub 2011 Jul 30.
8
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.腹型肥胖对与降压药物相关的不良代谢影响发生率的影响。
Hypertension. 2010 Jan;55(1):61-8. doi: 10.1161/HYPERTENSIONAHA.109.139592. Epub 2009 Nov 16.
9
Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.心血管治疗与相关的葡萄糖稳态:对血糖异常连续体的影响
J Am Coll Cardiol. 2009 Feb 3;53(5 Suppl):S28-34. doi: 10.1016/j.jacc.2008.10.037.
10
Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities.2型糖尿病中胰腺内分泌-外分泌通讯的减弱:胰腺细胞外基质超微结构异常。
J Cardiometab Syndr. 2008 Fall;3(4):234-43. doi: 10.1111/j.1559-4572.2008.00024.x.
引言:心脏代谢综合征中的器官受累情况。
J Cardiometab Syndr. 2006 Winter;1(1):16-24. doi: 10.1111/j.0197-3118.2006.05454.x.
4
Nonalcoholic steatohepatitis and the cardiometabolic syndrome.非酒精性脂肪性肝炎与心脏代谢综合征
J Cardiometab Syndr. 2006 Winter;1(1):36-40. doi: 10.1111/j.0197-3118.2006.05523.x.
5
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.阿利吉仑与缬沙坦联合应用于高血压患者的疗效与安全性:一项随机双盲试验
Lancet. 2007 Jul 21;370(9583):221-229. doi: 10.1016/S0140-6736(07)61124-6.
6
A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.直接肾素抑制剂阿利吉仑与赖诺普利在重度高血压患者中的耐受性比较。
J Hum Hypertens. 2007 Oct;21(10):780-7. doi: 10.1038/sj.jhh.1002220. Epub 2007 May 31.
7
Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus.2型糖尿病HIP大鼠模型中胰岛淀粉样变的纵向超微结构研究
Exp Biol Med (Maywood). 2007 Jun;232(6):772-9.
8
Isletopathy in Type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress.2型糖尿病中的胰岛病变:胰岛肾素血管紧张素系统、胰岛纤维化、胰岛淀粉样变、重塑及氧化应激的影响
Antioxid Redox Signal. 2007 Jul;9(7):891-910. doi: 10.1089/ars.2007.1610.
9
Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.盐皮质激素受体阻断可减弱肾素 - 血管紧张素 - 醛固酮系统刺激烟酰胺腺嘌呤二核苷酸磷酸氧化酶慢性过表达及心脏重塑。
Endocrinology. 2007 Aug;148(8):3773-80. doi: 10.1210/en.2006-1691. Epub 2007 May 10.
10
Redox imbalance in diabetes.
Antioxid Redox Signal. 2007 Jul;9(7):865-7. doi: 10.1089/ars.2007.1640.